Evidence map›Paper›PMID 39464430›Full record

ArticleACS omega2024

Accelerated Nanocomposite Hydrogel Gelation Times Independent of Gold Nanoparticle Ligand Functionality.

Brianna Couturier, Gloria Kozak, John Levering, Anna Zini, Meagan B Elinski

Abstract read
In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Brianna CouturierDepartment of Chemistry, Hope College, Holland, Michigan 49423, United States.
Gloria KozakDepartment of Chemistry, Hope College, Holland, Michigan 49423, United States.
John LeveringDepartment of Chemistry, Hope College, Holland, Michigan 49423, United States.
Anna ZiniDepartment of Chemistry, Hope College, Holland, Michigan 49423, United States.
Meagan B ElinskiDepartment of Chemistry, Hope College, Holland, Michigan 49423, United States.ORCID https://orcid.org/0000-0001-8664-770X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The expansive use of hydrogels in healthcare relies on carefully tuned properties in dynamic environments with predictable behavior, including time sensitive biological systems and biomedical applications. To meet demands in these settings, nanomaterials are often introduced to a hydrogel matrix which simultaneously elevates potential applications while adding complexity to fundamental characteristics. With respect to drug delivery, gold nanoparticles have modifiable surfaces to carry an array of targeted drug treatments. However, different molecules acting as capping ligands possess different chemical structures that can impact gelation times. To understand the influence of capping ligand chemistry on polyacrylamide (PAM) based nanocomposite hydrogel radical gelation time, gold nanoparticle (Au NP) capping ligands were selected to encompass varying functional groups and molecular weights: citrate, cetyltrimethylammonium bromide, polyvinylpyrrolidone, and poly(acrylic acid). Gelation times were quantified as the storage-loss moduli crossover point in rheological time sweeps at constant strain and frequency. The dominating factor for gelation time was the presence of Au NPs, independent of a diverse range of capping ligand structures. The gelation times were also markedly faster than the same capping ligand structures used as stand-alone molecular additives. The accelerated Au NP gelation times, under 2 min, are attributed to the Au NPs acting as a cross-linker, promoting gelation. These results bolster the potential implementation of Au NP nanocomposite hydrogels in time-sensitive biomedical applications as robust drug carriers.

Identifiers

PMID39464430
PMCPMC11500131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.